We are live on ! Find out more
FCM

FourWorld Capital Management Portfolio holdings

AUM $196M
1-Year Est. Return 42.39%
This Fund
S&P 500
This Quarter Est. Return
-8.6%
1 Year Est. Return
+42.39%
3 Year Est. Return
+114.45%
5 Year Est. Return
10 Year Est. Return
AUM
$63.1M
AUM Growth
+$259K
Cap. Flow
-$805K
Cap. Flow %
-1.28%
Top 10 Hldgs %
99.55%
Holding
16
New
1
Increased
3
Reduced
2
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 46.51%
2 Real Estate 11.7%
3 Materials 9.21%
4 Technology 4.93%
5 Consumer Discretionary 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVGN icon
1
Tevogen Bio Holdings
TVGN
$18.9M
$23.5M 37.32%
46,400
BVH
2
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$7.38M 11.7%
446,748
+17,200
+4% +$387K
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$6.86M 10.88%
3,200
-350
-10% -$139K
OMEX icon
4
Odyssey Marine Exploration
OMEX
$40.4M
$5.81M 9.21%
1,875,049
CEG icon
5
CALL
Constellation Energy
CEG
$98B
$4.79M 7.59%
+3,078
New +$227K
ABUS icon
6
Arbutus Biopharma
ABUS
$865M
$3.82M 6.05%
2,000,090
+199,090
+11% +$469K
MTBL
7
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$3.11M 4.93%
1,050,660
-509,700
-33% -$1.48M
LGSTU
8
DELISTED
Semper Paratus Acquisition Corporation Unit
LGSTU
$3M 4.75%
1,500,000
SLDP icon
9
Solid Power
SLDP
$468M
$2.51M 3.98%
477,129
EOLS icon
10
Evolus
EOLS
$394M
$1.98M 3.13%
245,590
+6,900
+3% +$73.2K
TVGNW icon
11
Tevogen Bio Warrant
TVGNW
$9.45M
$174K 0.28%
1,450,000
CELG.RT
12
Bristol-Myers Squibb Rights
CELG.RT
$69K 0.11%
100,000
PPC icon
13
Pilgrim's Pride
PPC
$6.82B
$23K 0.04%
1,000
BABA icon
14
CALL
Alibaba
BABA
$269B
$20K 0.03%
30
SPY icon
15
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
-2,500
Closed -$4K
CO
16
DELISTED
Global Cord Blood Corporation
CO
-113,911
Closed -$337K

Similar funds

FourWorld Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, FourWorld Capital Management held 16 positions worth $63.1M, up 0.41% from $62.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FourWorld Capital Management's Q3 2022 filing shows 1 new, 3 increased, 2 reduced and 2 closed positions. The largest sale was Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares), an estimated $1.48M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 49% a quarter earlier, followed by Real Estate and Materials.

  • FourWorld Capital Management added most to Arbutus Biopharma in Q3 2022, an estimated $469K increase.
  • FourWorld Capital Management's biggest Q3 2022 reduction was Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares), cutting an estimated $1.48M.
  • FourWorld Capital Management fully exited Global Cord Blood Corporation in Q3 2022, selling an estimated $337K.
  • FourWorld Capital Management's ten largest holdings make up 100% of its $63.1M portfolio in Q3 2022.
  • FourWorld Capital Management opened 1 new position and closed 2 in Q3 2022.
  • FourWorld Capital Management's portfolio value rose 0.41% quarter-over-quarter to $63.1M.

Based on FourWorld Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.